Iofina (IOF) Competitors

Iofina logo
GBX 48.38 -0.38 (-0.77%)
As of 11/20/2026 12:33 PM Eastern

IOF vs. ZTF, SYNT, TET, HDD, and ITX

Should you buy Iofina stock or one of its competitors? Iofina's main competitors and comparable companies include Zotefoams (ZTF), Synthomer (SYNT), Treatt (TET), Hardide (HDD), and Itaconix (ITX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "specialty chemicals" industry.

How does Iofina compare to Zotefoams?

Zotefoams (LON:ZTF) and Iofina (LON:IOF) are both small-cap materials companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

28.8% of Zotefoams shares are held by institutional investors. Comparatively, 1.3% of Iofina shares are held by institutional investors. 4.5% of Zotefoams shares are held by company insiders. Comparatively, 13.4% of Iofina shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Zotefoams has a net margin of 13.88% compared to Iofina's net margin of 12.91%. Zotefoams' return on equity of 18.18% beat Iofina's return on equity.

Company Net Margins Return on Equity Return on Assets
Zotefoams13.88% 18.18% 5.48%
Iofina 12.91%15.30%5.18%

Zotefoams currently has a consensus price target of GBX 605, suggesting a potential upside of 38.13%. Iofina has a consensus price target of GBX 70, suggesting a potential upside of 44.70%. Given Iofina's higher possible upside, analysts plainly believe Iofina is more favorable than Zotefoams.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zotefoams
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Zotefoams has a beta of 1.199, indicating that its stock price is 20% more volatile than the broader market. Comparatively, Iofina has a beta of 0.965, indicating that its stock price is 4% less volatile than the broader market.

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zotefoams£176.29M1.22£9.80M£50.298.71
Iofina£68.69M1.35£4.28M£4.5010.75

In the previous week, Zotefoams had 1 more articles in the media than Iofina. MarketBeat recorded 1 mentions for Zotefoams and 0 mentions for Iofina. Zotefoams' average media sentiment score of 0.00 equaled Iofina'saverage media sentiment score.

Company Overall Sentiment
Zotefoams Neutral
Iofina Neutral

Summary

Zotefoams beats Iofina on 10 of the 14 factors compared between the two stocks.

How does Iofina compare to Synthomer?

Iofina (LON:IOF) and Synthomer (LON:SYNT) are both small-cap materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

Iofina presently has a consensus price target of GBX 70, suggesting a potential upside of 44.70%. Synthomer has a consensus price target of GBX 118.75, suggesting a potential upside of 13.75%. Given Iofina's stronger consensus rating and higher possible upside, equities research analysts clearly believe Iofina is more favorable than Synthomer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Synthomer
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Iofina£68.69M1.35£4.28M£4.5010.75
Synthomer£1.80B0.10-£82.04M-£73.60N/A

1.3% of Iofina shares are held by institutional investors. Comparatively, 14.9% of Synthomer shares are held by institutional investors. 13.4% of Iofina shares are held by insiders. Comparatively, 5.0% of Synthomer shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Iofina has a net margin of 12.91% compared to Synthomer's net margin of -6.81%. Iofina's return on equity of 15.30% beat Synthomer's return on equity.

Company Net Margins Return on Equity Return on Assets
Iofina12.91% 15.30% 5.18%
Synthomer -6.81%-13.27%-0.28%

Iofina has a beta of 0.965, meaning that its share price is 4% less volatile than the broader market. Comparatively, Synthomer has a beta of 0.985, meaning that its share price is 2% less volatile than the broader market.

In the previous week, Synthomer had 1 more articles in the media than Iofina. MarketBeat recorded 1 mentions for Synthomer and 0 mentions for Iofina. Synthomer's average media sentiment score of 1.27 beat Iofina's score of 0.00 indicating that Synthomer is being referred to more favorably in the news media.

Company Overall Sentiment
Iofina Neutral
Synthomer Positive

Summary

Iofina beats Synthomer on 10 of the 15 factors compared between the two stocks.

How does Iofina compare to Treatt?

Treatt (LON:TET) and Iofina (LON:IOF) are both small-cap materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treatt£128.29M1.40£11.22M£7.2242.24
Iofina£68.69M1.35£4.28M£4.5010.75

In the previous week, Treatt's average media sentiment score of 0.00 equaled Iofina'saverage media sentiment score.

Company Overall Sentiment
Treatt Neutral
Iofina Neutral

Treatt presently has a consensus target price of GBX 242.50, indicating a potential downside of 20.49%. Iofina has a consensus target price of GBX 70, indicating a potential upside of 44.70%. Given Iofina's stronger consensus rating and higher probable upside, analysts plainly believe Iofina is more favorable than Treatt.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treatt
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

17.5% of Treatt shares are owned by institutional investors. Comparatively, 1.3% of Iofina shares are owned by institutional investors. 4.1% of Treatt shares are owned by company insiders. Comparatively, 13.4% of Iofina shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Iofina has a net margin of 12.91% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 15.30% beat Treatt's return on equity.

Company Net Margins Return on Equity Return on Assets
Treatt3.40% 3.22% 6.72%
Iofina 12.91%15.30%5.18%

Treatt has a beta of 0.907, meaning that its share price is 9% less volatile than the broader market. Comparatively, Iofina has a beta of 0.965, meaning that its share price is 4% less volatile than the broader market.

Summary

Treatt beats Iofina on 7 of the 13 factors compared between the two stocks.

How does Iofina compare to Hardide?

Iofina (LON:IOF) and Hardide (LON:HDD) are both small-cap materials companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

1.3% of Iofina shares are owned by institutional investors. Comparatively, 11.4% of Hardide shares are owned by institutional investors. 13.4% of Iofina shares are owned by company insiders. Comparatively, 65.7% of Hardide shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Iofina has a beta of 0.965, indicating that its share price is 4% less volatile than the broader market. Comparatively, Hardide has a beta of 1.093, indicating that its share price is 9% more volatile than the broader market.

Iofina has higher revenue and earnings than Hardide. Iofina is trading at a lower price-to-earnings ratio than Hardide, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Iofina£68.69M1.35£4.28M£4.5010.75
Hardide£8.02M12.56-£1.89M£1.8070.99

Hardide has a net margin of 15.60% compared to Iofina's net margin of 12.91%. Hardide's return on equity of 32.49% beat Iofina's return on equity.

Company Net Margins Return on Equity Return on Assets
Iofina12.91% 15.30% 5.18%
Hardide 15.60%32.49%-9.80%

In the previous week, Iofina's average media sentiment score of 0.00 equaled Hardide'saverage media sentiment score.

Company Overall Sentiment
Iofina Neutral
Hardide Neutral

Iofina presently has a consensus target price of GBX 70, indicating a potential upside of 44.70%. Given Iofina's stronger consensus rating and higher possible upside, research analysts plainly believe Iofina is more favorable than Hardide.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Hardide
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Iofina and Hardide tied by winning 7 of the 14 factors compared between the two stocks.

How does Iofina compare to Itaconix?

Itaconix (LON:ITX) and Iofina (LON:IOF) are both small-cap materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Itaconix currently has a consensus price target of GBX 375, suggesting a potential upside of 102.70%. Iofina has a consensus price target of GBX 70, suggesting a potential upside of 44.70%. Given Itaconix's higher probable upside, equities analysts plainly believe Itaconix is more favorable than Iofina.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itaconix
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Iofina has a net margin of 12.91% compared to Itaconix's net margin of -9.06%. Iofina's return on equity of 15.30% beat Itaconix's return on equity.

Company Net Margins Return on Equity Return on Assets
Itaconix-9.06% -15.42% -9.90%
Iofina 12.91%15.30%5.18%

Itaconix has a beta of 1.051, meaning that its stock price is 5% more volatile than the broader market. Comparatively, Iofina has a beta of 0.965, meaning that its stock price is 4% less volatile than the broader market.

In the previous week, Itaconix's average media sentiment score of 0.00 equaled Iofina'saverage media sentiment score.

Company Overall Sentiment
Itaconix Neutral
Iofina Neutral

8.8% of Itaconix shares are held by institutional investors. Comparatively, 1.3% of Iofina shares are held by institutional investors. 77.5% of Itaconix shares are held by company insiders. Comparatively, 13.4% of Iofina shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Iofina has higher revenue and earnings than Itaconix. Itaconix is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Itaconix£13.97M1.79-£1.49M-£9.20N/A
Iofina£68.69M1.35£4.28M£4.5010.75

Summary

Iofina beats Itaconix on 7 of the 12 factors compared between the two stocks.

Get Iofina News Delivered to You Automatically

Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IOF vs. The Competition

MetricIofinaChemicals IndustryMaterials SectorLON Exchange
Market Cap£92.81M£10.82B£4.23B£2.67B
Dividend Yield2.88%3.05%4.38%5.11%
P/E Ratio10.7532.9025.1022.78
Price / Sales1.352.245.514.91
Price / Cash7.9614.0120.4720.23
Price / Book2.153.123.632.40
Net Income£4.28M£237.41M£159.72M£5.88B
7 Day Performance-4.61%-6.36%-8.82%-3.59%
1 Month Performance0.36%-7.06%-11.32%-3.91%
1 Year Performance130.36%7.13%0.99%5.17%

Iofina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IOF
Iofina
2.0178 of 5 stars
GBX 48.38
-0.8%
GBX 70
+44.7%
+130.4%£92.81M£68.69M10.7595
ZTF
Zotefoams
3.7433 of 5 stars
GBX 450.50
-0.6%
GBX 605
+34.3%
+9.0%£222.11M£176.29M8.96549
SYNT
Synthomer
1.597 of 5 stars
GBX 119
+3.0%
GBX 118.75
-0.2%
+109.6%£195.09M£1.80BN/A4,200
TET
Treatt
N/AGBX 305
flat
GBX 242.50
-20.5%
N/A£180.06M£128.29M42.24350
HDD
Hardide
N/AGBX 123.80
-1.0%
N/A+1,687.1%£97.60M£8.02M68.7846

Related Companies and Tools


This page (LON:IOF) was last updated on 11/22/2026 by MarketBeat.com Staff.
From Our Partners